Development of a pluripotent stem cell derived neuronal model to identify chemically induced pathway perturbations in relation to neurotoxicity: Effects of CREB pathway inhibition
Open Access
- 1 October 2014
- journal article
- research article
- Published by Elsevier in Toxicology and Applied Pharmacology
- Vol. 280 (2) , 378-388
Abstract
No abstract availableKeywords
Funding Information
- eu (266753)
- DETECTIVE (266838)
This publication has 56 references indexed in Scilit:
- Regenerative toxicology: the role of stem cells in the development of chronic toxicitiesExpert Opinion on Drug Metabolism & Toxicology, 2013
- Insight into the neuroproteomics effects of the food-contaminant non-dioxin like polychlorinated biphenylsJournal of Proteomics, 2012
- Evaluation of 309 Environmental Chemicals Using a Mouse Embryonic Stem Cell Adherent Cell Differentiation and Cytotoxicity AssayPLOS ONE, 2011
- Meta-analysis of the heterogeneity of X chromosome inactivation in human pluripotent stem cellsStem Cell Research, 2011
- Differences in the Microrheology of Human Embryonic Stem Cells and Human Induced Pluripotent Stem CellsBiophysical Journal, 2010
- Functional Protein Network Activation Mapping Reveals New Potential Molecular Drug Targets for Poor Prognosis Pediatric BCP-ALLPLOS ONE, 2010
- DFP initiated early alterations of PKA/p-CREB pathway and differential persistence of β-tubulin subtypes in the CNS of hens contributes to OPIDNToxicology and Applied Pharmacology, 2009
- Functional Repression of cAMP Response Element in 6-Hydroxydopamine-treated Neuronal CellsJournal of Biological Chemistry, 2006
- Identification of small-molecule antagonists that inhibit an activator:coactivator interactionProceedings of the National Academy of Sciences, 2004
- A comparison of normalization methods for high density oligonucleotide array data based on variance and biasBioinformatics, 2003